Stay Updated With Our Research
Subscribe to our lab newsletter for the latest findings.
Shank3 mutation impairs glutamate signaling and myelination in ASD mouse model and human iPSC-derived OPCs |
Fischer I, Shohat S, Leichtmann-Bardoogo Y, Nayak R, Wiener G, Rosh I, Shemen A, Tripathi U, Rokach M, Bar E, Hussein Y, Carolin Castro A, Chen G, Soffer A, Schokoroy-Trangle S, Elad-Sfadia G, Assaf Y, Schroeder A, Monteiro P, Stern S, Maoz B and Barak B.
2024
In individuals with Williams syndrome, dysregulation of methylation in non-coding regions of neuronal and oligodendrocyte DNA is associated with pathology and cortical development |
Schokoroy Trangle S, Rosenberg T, Parnas H, Levy G, Bar E, Marco A and Barak B.
2022
PubMed |
Neuronal deletion of Gtf2i results in developmental microglial alterations in a mouse model related to Williams syndrome |
Bar E, Fischer I, Rokach M, Elad-Sfadia G, Shirenova S, Ophir O, Schokoroy-Trangle S,
Okun E and Barak B.
2024
Tackling myelin deficits in neurodevelopmental disorders using drug delivery systems |
Rokach M, Portioli C, Brahmachari S, Estevão BM, Decuzzi P and Barak B.
2024
Neuronal Gtf2i deletion alters mitochondrial and autophagic properties |
Nir Sade A, Levy G, Trangle SS, Sfadia GE, Bar E, Ophir O, Fischer I, Rokach M, Atzmon A, Parnas H, Rosenberg T, Marco A, Stein OE & Barak B.
2023
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioral and myelin alterations rescuable by a remyelinating drug |
Barak B , Zhang Z, Liu Y, Nir A, Trangle S, Ennis M, Levandowski K.M, Wang D, Quast K, L. Boulting G.L, Li Y, Bayarsaihan D, He Z and Feng G.
2019
We believe in the power of science to improve lives, and your support helps us achieve our mission.
Research funds are limited, especially for rare diseases, while costs continue to rise.
Every amount makes a difference!
Every donation helps and brings us one step closer to improve the understanding and treatment of Williams syndrome and autism spectrum disorders (ASD).
